Government Affairs
Refine Search
Pharmaceutical
Even as US President Barack Obama is slated to be the chief guest at India's Republic Day Parade on January 26, action has revved up behind the scenes with the readying of the draft of the national Intellectual Property Rights policy, reports The Pharma Letter’s India correspondent. 7 January 2015
Biosimilars
US politics will continue to be characterized by partisanship as the Republican majorities in the House and Senate will look to dismantle unpopular aspects of the Patient Protection and Affordable Care Act, the Obama Administration’s landmark health care reform legislation, says Steven Burrill, chief executive of Burrill LLC and Burrill Media in his annual predictions for the life sciences in the new year. 24 December 2014
Pharmaceutical
At the instance of Association of Pharmaceutical Research and Development (APRAD), the Ministry of Health of Ukraine (MoH) held an official meeting with the international research-based pharmaceutical industry to discuss further cooperation as a part of essential health care reform. 22 December 2014
Pharmaceutical
Sussan Ley has been appointed as the Australian Minister for Health, and replaces Peter Dutton. 22 December 2014
Generics
Early January 2015, the Indian government is to come out with a new list of life saving drugs whose prices would be controlled. A core committee, under the Director General of the Indian Council for Medical Research has been established to suggest a new list of medicines that can be brought under price control, reports The Pharma Letter’s India correspondent. 22 December 2014
Biotechnology
France Biotech, an association for life sciences entrepreneurs, has published the twelfth edition of its Panorama of the Life Sciences industry. 18 December 2014
Generics
Government hospitals in India that lack medicines, are overcrowded and understaffed, may soon be a thing of the past. Even as a thorough streamlining of systems is in the offing, in the distribution of free generic drugs and ensuring adequate staff at government health institutions, the Indian government is also readying to fix prices of patented drugs in the country, reports The Pharma Letter’s India correspondent. 11 December 2014
Biotechnology
For the Australian biotechnology industry and for trade group AusBiotech, the past year has been another action-packed period in policy terms as well as the year the Australian biotech industry was ranked fourth in the world, the association says. 11 December 2014
Pharmaceutical
In September Enrico Gasbarra, a newly-elected Italian Member of the European Parliament (BEP) from the S&D, submitted a written question to the Commission on parallel trade. He alleges parallel distribution to be the cause for quotas to be established and shortages of medicines to occur. 10 December 2014
Pharmaceutical
Pharmaceutical spending has fallen nearly 30% in Spain in last four years. According to IMS Health data, it will continue falling in 2014 (-2%) and 2015 (-3.5%) if structural measures are not taken to correct it. 8 December 2014
Biotechnology
Trade group AusBiotech has made a submission to the Australian federal government’s consultation regarding “Boosting commercial returns from research,” as part of the Industry Innovation and Competitiveness Agenda. 5 December 2014
Pharmaceutical
The Australian Competition and Consumer Commission has granted interim authorization to trade body Medicines Australia for edition 17 of its Code of Conduct, a voluntary industry code of conduct for the prescription medicines industry in Australia. 4 December 2014
Pharmaceutical
Urgent action is needed to address the current issues relating to the management of health care-acquired infections (HAIs) and Clostridium difficile infection (CDI), experts agreed at an event yesterday at the European Parliament. 3 December 2014
Pharmaceutical
The UK prime minister David Cameron is to announce a £15 million ($24 million) commitment to a new fund to boost dementia research in the Autumn Statement, which will be made tomorrow. 2 December 2014
Pharmaceutical
Last week, US Representatives Gus Bilirakis (Republican, Florida) and G K Butterfield (Democrat, North Carolina) took a bipartisan step on behalf of patients with rare diseases by introducing the Orphan Product Extensions Now Accelerating Cures and Treatments Act of 2014 (OPEN ACT). 26 November 2014
Generics
Commenting on recent evaluations of generic drug prices, Ralph Neas, president and chief executive of the US Generic Pharmaceutical Association (GPhA) argued that generic medicines are a critical part of system-wide efforts to hold down health care costs. 24 November 2014
Pharmaceutical
The discount negotiated by the French government on hepatitis C drug Sovaldi (sofosbuvir), produced by US biotech major Gilead Sciences, makes it the ‘lowest price in Europe,’ according to the country’s health ministry. 21 November 2014
Biotechnology
The UK government has announced a substantial investment package from industry, and that it is to carry out a review of the life sciences sector under the name Innovative Medicines and MedTech Review. 20 November 2014
Pharmaceutical
Last month, Treasury Minister David Gauke gave a robust defence of the UK's Patent Box scheme, which allows profits from technologies protected by a UK or other qualifying patents to benefit from a lower rate of corporation tax. 19 November 2014
Pharmaceutical
Australia yesterday signed the Free Trade Agreement with China, after nearly 10 years of negotiations, with Trade and Investment Minister Andrew Robb saying the deal was the most significant China had ever signed with a developed country. 18 November 2014
Pharmaceutical
The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human Services (HHS) President-elect Donald Trump sent shares in vaccine companies sharply downwards. 22 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
The Danish government’s newly-unveiled health reform has been praised for tackling chronic disease care and health inequalities while driving health innovation. 18 November 2024
Pharmaceutical
New research published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) provides in-depth analysis of the economic footprint of the pharmaceutical industry in Europe, across member states and compares Europe to other regions of the world. 18 November 2024
Pharmaceutical
Johnson & Johnson has taken legal action to defend a contentious rebate initiative, filing a lawsuit in the US District Court for the District of Columbia. 15 November 2024
Pharmaceutical
The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research results in the sphere, or an ominous stance taken by a major regulator on a key filing, but rather a political development that could spell trouble for the vaccines field as a whole. 15 November 2024
Biotechnology
BeiGene has announced plans to rebrand as BeOne Medicines, a move the cancer specialist says reflects its commitment to fighting cancer through collaboration. 15 November 2024
Pharmaceutical
Danish patients are being offered fewer innovative treatments than Norwegians and Swedes, a new estimate from the Danish Medicines Council shows. 11 November 2024
Pharmaceutical
According to the Swedish pharma trade group Lif, it is positive that, in the updated life science strategy, the government expresses an ambition for Sweden to become more attractive for research investments. 11 November 2024
Pharmaceutical
Li Li, Commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, have signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices. 11 November 2024
Pharmaceutical
Following the news that Donald Trump is the winner of the 2024 US Presidential Election, Morningstar Equity analyst Julie Utterback has published a new note about the impact of this on the managed-care industry. 7 November 2024
Pharmaceutical
UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China. 7 November 2024
Pharmaceutical
Some of the UK’s leading academics and industry professionals have welcomed Chancellor Rachel Reeves’ £520 million ($669 million) pledge to develop the country’s medicine manufacturing capabilities. 6 November 2024
Pharmaceutical
European regulators will decide by December 6 whether Novo Holdings, the controlling shareholder of Danish pharma giant Novo Nordisk, can finalize its $16.5 billion acquisition of contract drug manufacturer Catalent. 5 November 2024
Pharmaceutical
The Danish government is rolling out the red carpet and welcomes several pharmaceutical companies. 4 November 2024
Generics
Medicines for Europe has launched a study of market barriers faced by European generics and biosimilar pharmaceutical companies operating in 11 key third-country markets. 31 October 2024
Pharmaceutical
Following the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) welcomes Chancellor Rachel Reeves’ measures to improve UK life sciences competitiveness. 30 October 2024
Pharmaceutical
HOPO Therapeutics has been awarded a contract valued at up to $226 million from the Biomedical Advanced Research and Development Authority (BARDA). 29 October 2024
Pharmaceutical
The Danish government has presented part of the plan for a future life science strategy, which has been welcomed by the industry. 28 October 2024
Biotechnology
Legend Biotech has removed Genscript Biotech as its majority shareholder, in a move coinciding with rising US concerns over Chinese ties within the biotech sector. 24 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze